Fleurence R[au] - Search Results

Year	Number of Results
2002	1
2004	2
2005	3
2006	3
2007	5
2009	2
2010	5
2011	2
2012	1
2013	6
2014	6
2015	2
2016	1
2019	3
2020	3
2022	1
2023	3
2024	0

1

Fleurence RL, Collins FS. Fleurence RL, et al. JAMA. 2023 Sep 5;330(9):878. doi: 10.1001/jama.2023.11763. JAMA. 2023. PMID: 37668623 No abstract available.

2

Electronic health data quality maturity model for medical device evaluations.

Tcheng JE, Fleurence R, Sedrakyan A. Tcheng JE, et al. Among authors: fleurence r. BMJ Surg Interv Health Technol. 2020 May 15;2(1):e000043. doi: 10.1136/bmjsit-2020-000043. eCollection 2020. BMJ Surg Interv Health Technol. 2020. PMID: 35047793 Free PMC article. No abstract available.

3

Strengthening the Evidence Base for Pediatric Medical Devices Using Real-World Data.

Fleurence RL, Forrest CB, Shuren J. Fleurence RL, et al. J Pediatr. 2019 Nov;214:209-211. doi: 10.1016/j.jpeds.2019.06.060. Epub 2019 Aug 1. J Pediatr. 2019. PMID: 31378521 Review. No abstract available.

4

A Step Closer to Better Research Prioritization? The ISPOR Value of Information Task Force Reports.

Fleurence RL, Selby JV. Fleurence RL, et al. Value Health. 2020 Mar;23(3):287-288. doi: 10.1016/j.jval.2020.01.003. Epub 2020 Feb 25. Value Health. 2020. PMID: 32197721 Free article. No abstract available.

5

A systematic review of approaches for engaging patients for research on rare diseases.

Forsythe LP, Szydlowski V, Murad MH, Ip S, Wang Z, Elraiyah TA, Fleurence R, Hickam DH. Forsythe LP, et al. Among authors: fleurence r. J Gen Intern Med. 2014 Aug;29 Suppl 3(Suppl 3):S788-800. doi: 10.1007/s11606-014-2895-9. J Gen Intern Med. 2014. PMID: 25047393 Free PMC article. Review.

6

Evidence-based prescribing: combining network meta-analysis with multicriteria decision analysis to choose among multiple drugs.

Naci H, van Valkenhoef G, Higgins JP, Fleurence R, Ades AE. Naci H, et al. Among authors: fleurence r. Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):787-92. doi: 10.1161/CIRCOUTCOMES.114.000825. Epub 2014 Aug 5. Circ Cardiovasc Qual Outcomes. 2014. PMID: 25097214 Review. No abstract available.

7

Economic burden of multiple sclerosis: a systematic review of the literature.

Naci H, Fleurence R, Birt J, Duhig A. Naci H, et al. Among authors: fleurence r. Pharmacoeconomics. 2010;28(5):363-79. doi: 10.2165/11532230-000000000-00000. Pharmacoeconomics. 2010. PMID: 20402540 Review.

8

Review of the economic and quality-of-life burden of cervical human papillomavirus disease.

Fleurence RL, Dixon JM, Milanova TF, Beusterien KM. Fleurence RL, et al. Am J Obstet Gynecol. 2007 Mar;196(3):206-12. doi: 10.1016/j.ajog.2007.01.028. Am J Obstet Gynecol. 2007. PMID: 17346523 Review.

9

A systematic review of augmentation strategies for patients with major depressive disorder.

Fleurence R, Williamson R, Jing Y, Kim E, Tran QV, Pikalov AS, Thase ME. Fleurence R, et al. Psychopharmacol Bull. 2009;42(3):57-90. Psychopharmacol Bull. 2009. PMID: 19752841 Review.

10

A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes.

Hutchins V, Zhang B, Fleurence RL, Krishnarajah G, Graham J. Hutchins V, et al. Among authors: fleurence rl. Curr Med Res Opin. 2011 Jun;27(6):1157-68. doi: 10.1185/03007995.2011.570745. Epub 2011 Apr 5. Curr Med Res Opin. 2011. PMID: 21466277 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

47 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year